Interactions Between Diet Medications (Diabetes Drugs) GLP-1 receptor agonists (Mounjaro, Ozempic, Rybelsus), SGLT2 inhibitors (Lusefi), and Metformin have a low risk of hypoglycemia alone but increase the risk when combined
Ro has also expanded its medication offerings, adding Zepbound following its U.S
Therefore, it is recommended that colorectal cancer patients be cautious with foods high in EA (20)
What details should I include in my side effect log
Appetite returns to pre-treatment levels, often within days to weeks
Le Gal K, Ibrahim MX, Wiel Cl, Sayin VI, Akula MK, Karlsson C, Dalin MG, Akyrek LM, Lindahl P, Nilsson J, Bergo MO